None listed
Conditions
Interventions
Medical Device : The subject visits the clinical trial institution three to for times during chemotherapy or concurrent chemoradiotherapy (for4 to 6 weeks), and applies the clinical device (PetalB las
Sponsors
Soon Chun Hyang University Hospital Cheonan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Those who have been diagnosed with cancer in one organ and is receiving chemotherapy or concurrent chemo-radiotherapy - Those with WHO mucositis scale grade 2 or higher - Adults over 19 years old - Those who have no problem expressing their opinions - Those who voluntarily participated and signed the subject's consent of this clinical trial
Exclusion criteria
Exclusion criteria: - Pregnants, Those who have a mental disorder - Those who are diagnosed with double primary cancer or distant metastasis with unknown origin - Those who have trouble with mouth opening (difficult to open mouth more than 1cm2) - Those who have uncontrolled connective tissue disorder - Smokers - Those who have received light-based treatment within the last 6 weeks - Those who are sensitive to laser light or taking medications that are related to laser light sensitivity - Those who have participated in another clinical trial within the last month - Those who have difficulty to participate in a clinical trial or receive treatment - Those who have been thought the clinical trials cannot be performed properly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary endpoint: comparison of the ratio of moderate to severe oral mucositis (more than WHO grade 2) before treatment and after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| secondary endpoint: Comparison of European Organization for Research and Treatment of Cancer Quality of life Questionnaire (EORTC QLQ-C30) scores before and after treatment | — |
Countries
Korea, Republic of
Contacts
Public ContactJung Eun Kim
Soon Chun Hyang University Hospital Cheonan
Outcome results
None listed